{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:30:49Z","timestamp":1781821849372,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Biobanks that hold blood, urine and kidney tissue are key for translational nephrology research but are few and have limited availability. We describe the organization, baseline characteristics, and generalizability of a low-cost national biobank.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>Eight Norwegian hospitals participated in this multi-center, prospective cohort study and biobank initiative. Patients referred for routine clinical native kidney biopsies were eligible for inclusion, starting September 2020. Extensive information on medical history and risk factors were collected into an encrypted on-line database by the treating nephrologist. A comprehensive standardized panel of blood and urine tests were analyzed in the clinical routine and registered along with the full histology report. Extra urine and blood samples were collected, aliquoted and prepared locally within two hours, frozen at -80\u00a0C, and later sent to a central government-funded biorepository together with remaining kidney biopsy material.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>By September 2023, a total of 633 patients were included out of 1050 eligible patients. Mean age was 52.6 years (SD 18.7), 384 (61%) were men, and participants displayed a wide spectrum of kidney disease with mean estimated glomerular filtration rate (eGFR) 53 mL\/min\/1.73m<jats:sup>2<\/jats:sup>. The most frequent biopsy indications were progressive chronic kidney disease (CKD) of unknown cause, acute kidney disease, and isolated hematuria\/proteinuria. The most frequent diagnoses were IgA nephropathy (21%), arterionephrosclerosis (13%), and diabetes nephropathy (9%). Biopsy indications and diagnoses were similar to the spectrum typically seen in Norway and other western countries, and similar population level kidney health measures were demonstrated for Norway, United Kingdom, and USA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>We demonstrate the feasibility of establishing a large national kidney biopsy biobank across a variety of clinical and histopathologic diagnoses. Blood and urine were stored, accompanied by kidney tissue, at a moderate cost due to a combination of a dedicated nephrology workforce, routine clinical care, and established biobank facilities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04007-4","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T17:39:39Z","timestamp":1739468379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Norwegian kidney biopsy biobank (NorKiBB): organization, baseline characteristics, and generalizability of a low-cost national biobank"],"prefix":"10.1186","volume":"26","author":[{"given":"Marius Altern","family":"\u00d8vrehus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut Asbj\u00f8rn","family":"Rise Langlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Leh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Eikrem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solfrid","family":"Romundstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5vard","family":"Aksnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingjerd Wangensteen","family":"Manner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Aalborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit D.","family":"Solbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse G.","family":"G\u00f8ransson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H.","family":"Ix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein I.","family":"Hallan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"issue":"7","key":"4007_CR1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473\u201385.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"4007_CR2","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/ckj\/sfab070","volume":"14","author":"R Vanholder","year":"2021","unstructured":"Vanholder R, et al. Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney. Clin Kidney J. 2021;14(7):1719\u201330.","journal-title":"Clin Kidney J"},{"issue":"2","key":"4007_CR3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.kint.2017.04.019","volume":"92","author":"C Baigent","year":"2017","unstructured":"Baigent C, et al. Challenges in conducting clinical trials in nephrology: conclusions from a kidney disease-improving global outcomes (KDIGO) Controversies Conference. Kidney Int. 2017;92(2):297\u2013305.","journal-title":"Kidney Int"},{"issue":"5","key":"4007_CR4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2013.512","volume":"85","author":"N Dhaun","year":"2014","unstructured":"Dhaun N, et al. Utility of renal biopsy in the clinical management of renal disease. Kidney Int. 2014;85(5):1039\u201348.","journal-title":"Kidney Int"},{"issue":"2","key":"4007_CR5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ckj\/sfac212","volume":"16","author":"S Copur","year":"2023","unstructured":"Copur S, et al. Novel strategies in nephrology: what to expect from the future? Clin Kidney J. 2023;16(2):230\u201344.","journal-title":"Clin Kidney J"},{"issue":"4","key":"4007_CR6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jama.2014.16363","volume":"313","author":"T Tomlinson","year":"2015","unstructured":"Tomlinson T, et al. Moral concerns and the willingness to donate to a research biobank. JAMA. 2015;313(4):417\u20139.","journal-title":"JAMA"},{"issue":"7","key":"4007_CR7","doi-asserted-by":"crossref","first-page":"e0159113","DOI":"10.1371\/journal.pone.0159113","volume":"11","author":"RG De Vries","year":"2016","unstructured":"De Vries RG, et al. Understanding the Public\u2019s reservations about Broad Consent and Study-By-Study consent for donations to a Biobank: results of a National Survey. PLoS ONE. 2016;11(7):e0159113.","journal-title":"PLoS ONE"},{"issue":"6","key":"4007_CR8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/ndt\/gfh181","volume":"19","author":"H Schmid","year":"2004","unstructured":"Schmid H, et al. Gene expression analysis in renal biopsies. Nephrol Dial Transpl. 2004;19(6):1347\u201351.","journal-title":"Nephrol Dial Transpl"},{"key":"4007_CR9","unstructured":"Registry TNR. Annual Report 2022 The Norwegian Renal Registry. 2022: Oslo, Norway."},{"issue":"2","key":"4007_CR10","doi-asserted-by":"crossref","first-page":"sfad281","DOI":"10.1093\/ckj\/sfad281","volume":"17","author":"BA Boerstra","year":"2024","unstructured":"Boerstra BA, et al. The ERA Registry Annual Report 2021: a summary. Clin Kidney J. 2024;17(2):sfad281.","journal-title":"Clin Kidney J"},{"issue":"8","key":"4007_CR11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","volume":"4","author":"JP Lash","year":"2009","unstructured":"Lash JP, et al. Chronic renal insufficiency cohort (CRIC) study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009;4(8):1302\u201311.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"4007_CR12","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"6","key":"4007_CR13","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ndt\/gft307","volume":"29","author":"GJ Navis","year":"2014","unstructured":"Navis GJ, et al. The Biobank of Nephrological diseases in the Netherlands cohort: the string of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands. Nephrol Dial Transpl. 2014;29(6):1145\u201350.","journal-title":"Nephrol Dial Transpl"},{"issue":"8","key":"4007_CR14","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/ndt\/gft388","volume":"29","author":"B Stengel","year":"2014","unstructured":"Stengel B, et al. The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study. Nephrol Dial Transpl. 2014;29(8):1500\u20137.","journal-title":"Nephrol Dial Transpl"},{"issue":"Suppl 1","key":"4007_CR15","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1055\/s-2005-858235","volume":"67","author":"R Holle","year":"2005","unstructured":"Holle R, et al. KORA\u2013a research platform for population based health research. Gesundheitswesen. 2005;67(Suppl 1):S19\u201325.","journal-title":"Gesundheitswesen"},{"issue":"6","key":"4007_CR16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10157-010-0328-6","volume":"14","author":"E Imai","year":"2010","unstructured":"Imai E, et al. Chronic kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol. 2010;14(6):558\u201370.","journal-title":"Clin Exp Nephrol"},{"key":"4007_CR17","doi-asserted-by":"crossref","unstructured":"Moledina DG et al. Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. J Clin Invest, 2023. 133(13).","DOI":"10.1172\/JCI168950"},{"issue":"8","key":"4007_CR18","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1681\/ASN.2017121260","volume":"29","author":"A Srivastava","year":"2018","unstructured":"Srivastava A, et al. The Prognostic Value of Histopathologic Lesions in native kidney biopsy specimens: results from the Boston kidney biopsy cohort study. J Am Soc Nephrol. 2018;29(8):2213\u201324.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"4007_CR19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41588-022-01097-w","volume":"54","author":"H Liu","year":"2022","unstructured":"Liu H, et al. Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease. Nat Genet. 2022;54(7):950\u201362.","journal-title":"Nat Genet"},{"issue":"11","key":"4007_CR20","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/ndt\/gfad110","volume":"38","author":"MW Taal","year":"2023","unstructured":"Taal MW, et al. Associations with age and glomerular filtration rate in a referred population with chronic kidney disease: methods and baseline data from a UK multicentre cohort study (NURTuRE-CKD). Nephrol Dial Transpl. 2023;38(11):2617\u201326.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"4007_CR21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12882-020-02016-z","volume":"21","author":"E Kang","year":"2020","unstructured":"Kang E, et al. Biobanking for glomerular diseases: a study design and protocol for KOrea Renal biobank NEtwoRk system TOward NExt-generation analysis (KORNERSTONE). BMC Nephrol. 2020;21(1):367.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4007_CR22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12882-017-0669-4","volume":"18","author":"DA Muruve","year":"2017","unstructured":"Muruve DA, et al. The biobank for the molecular classification of kidney disease: research translation and precision medicine in nephrology. BMC Nephrol. 2017;18(1):252.","journal-title":"BMC Nephrol"},{"key":"4007_CR23","doi-asserted-by":"crossref","unstructured":"Owens EP et al. An Australian chronic kidney Disease Biobank to support Future Research. Open J Bioresources, 2019. 6.","DOI":"10.5334\/ojb.56"},{"issue":"3","key":"4007_CR24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.kint.2020.08.039","volume":"99","author":"IH de Boer","year":"2021","unstructured":"de Boer IH, et al. Rationale and design of the kidney Precision Medicine Project. Kidney Int. 2021;99(3):498\u2013510.","journal-title":"Kidney Int"},{"issue":"1","key":"4007_CR25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ije\/2.1.81","volume":"2","author":"LM Irgens","year":"1973","unstructured":"Irgens LM, Bjerkedal T. Epidemiology of leprosy in Norway: the history of the National Leprosy Registry of Norway from 1856 until today. Int J Epidemiol. 1973;2(1):81\u20139.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"4007_CR26","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1093\/ije\/dyac095","volume":"52","author":"BO \u00c5svold","year":"2023","unstructured":"\u00c5svold BO, et al. Cohort Profile Update: the HUNT study, Norway. Int J Epidemiol. 2023;52(1):e80\u201391.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"4007_CR27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ije\/dyr049","volume":"41","author":"BK Jacobsen","year":"2012","unstructured":"Jacobsen BK, et al. Cohort profile: the Tromso Study. Int J Epidemiol. 2012;41(4):961\u20137.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"4007_CR28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00428-021-03151-0","volume":"479","author":"L Annaratone","year":"2021","unstructured":"Annaratone L, et al. Basic principles of biobanking: from biological samples to precision medicine for patients. Virchows Arch. 2021;479(2):233\u201346.","journal-title":"Virchows Arch"}],"updated-by":[{"DOI":"10.1186\/s12882-025-04055-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000}}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04007-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04007-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04007-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T16:49:00Z","timestamp":1742921340000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04007-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4007"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04007-4","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12882-025-04055-w","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12882-025-04055-w","URL":"https:\/\/doi.org\/10.1186\/s12882-025-04055-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NorKiBB was approved by the Regional Committee for Medical Research Ethics Central Norway, as well as by the local data protection boards\/data access committees in all of the participating hospitals\u2019 ethics committees: the Data Protection Officer at St. Olavs Hospital, Trondheim University Hospital, Trondheim; the Regional Committee for Medical Research Ethics Western Norway for Haukeland University Hospital, Bergen; the Data Access Committee at Levanger Hospital, Levanger; the Data Protection Officer at Lillehammer Hospital, Lillehammer; the Data Protection Officer at Oslo University Hospital, Ullev\u00e5l, Oslo; the Data Protection Office at Akershus Oslo University Hospital, L\u00f8renskog; the Data Protection Official at the University Hospital of North Norway, Troms\u00f8; and The Research Department at Stavanger University Hospital, Stavanger. All patients gave their written, informed consent after having received oral and written information about the project, possible disadvantages, and benefits in accordance with the General Data Protection Regulation (GDPR). A copy of the consent form is available in the Supplementary section. All experiments were performed in accordance with the Norwegian Act on medical and health research, and the Personal Data Act. The experiments were conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MA\u00d8: Has received salary from the Western Norway Regional Health Authority the last years on an unrelated project; has received an institutional research grant from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) on an unrelated project; has received a speaker\u2019s fee from AstraZeneca. MGS: Has received an institutional research grant from the NIH-NIDDK, an institutional grant from Bayer Pharmaceuticals, NIH-NIA, NIDDK, NHLBI; consultant fees from Cricket Health; honoraria from Boehringer Ingelheim, Astra Zeneca, and Bayer Pharmaceuticals; payment from Hagens Berman International Law Firm. JI has received consulting fees from Astra Zeneca, Bayer Pharmaceuticals, and Jnana; support from Genentech. CA has received honoraria from Astra Zeneca, Boehringer Ingelheim. MDS has received honoraria from Astra Zeneca, Bayer Pharmaceuticals, Boehringer Ingelheim, Baxter, and Novartis; and participated in DSMB or AB of Viphor Pharma. All other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"76"}}